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Abstract
This matched case-control study examined the association between environmental heat
exposure and hospital encounters with acute kidney injury (AKI) among adults, 66 years
and older, in the province of Ontario, Canada. We matched 52,913 cases who had an AKI
event during the warm seasons (April to September) of 2005 to 2012 with 174,222
controls who did not have an AKI event. We matched cases to controls on date, age, sex,
residential status, income, and history of chronic kidney disease using a variable one to
four matching ratio. We classified heat periods as three consecutive days where the 95th
percentile of area-specific daily maximum temperature was reached or exceeded. We
determined associations using conditional logistic regression. Compared to non-heat
periods, high heat periods were significantly associated with greater risk of AKI (adjusted
odds ratio 1.11, 95% confidence interval 1.00 to 1.23).
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Acute kidney injury, administrative data, case-control, environmental heat, maximum
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Chapter 1

1

Introduction

Climatological research strongly indicates that green house gas emissions are
contributing to the warming of the Earth’s surface.1 There is near unanimous consensus
that climbing temperatures will coincide with more frequent and severe heat waves.2 This
is alarming as the loss of life attributed to heat events is of considerable magnitude.3
Unmitigated environmental heat has also been repeatedly demonstrated to induce multiorgan morbidity,4 with the kidneys appearing particularly vulnerable.5,6 The volume
contractions that accompany environmental heat may lead to the short-term loss of
kidney function.7 Acute kidney injury (AKI) is the medical term for this loss of function.8
AKI is a serious health condition and its occurrence is associated with increased risk of
chronic kidney disease, reduced quality of life, and death.9–12 Older adults may be
disproportionately impacted by heat-associated AKI as a result of declining
thermoregulatory abilities,13,14 and age-based declines in kidney function.15
In previous studies environmental heat has been shown to consistently and significantly
exacerbate the risk of AKI across the United States and Australia.16–25 However, the
generalizability of the association between environmental heat and AKI to more northern
latitudes has not been adequately investigated. Moreover existing studies have lacked
outcome focus and methodological rigor. To remedy these knowledge gaps, we
performed a matched case-control study with the purpose of evaluating the association
between environmental heat and hospital encounters with AKI among older adults in
Ontario, Canada.
The remainder of this thesis is structured into the following chapters: 2 Literature review,
3 Objectives, 4 Methods, 5 Results, and 6 Discussion. In Chapter 2 we describe what
constitutes environmental heat and review effect modifiers of heat health relationships as
well as risk factors for heat-related illness. This is followed by an explanation of what
constitutes AKI and the salient risk factors for AKI. Finally, we bring the two together to
explore what is known of the association between environmental heat and AKI. In
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Chapter 3 we explicitly state the objectives of our research project. In Chapter 4 we
provide a transparent and detailed summary of our methods. In Chapter 5 we present our
written results and accompanying figures and tables. Lastly, in Chapter 6, we discuss our
findings, contextualizing them within the current literature and touching briefly on their
implications. We also reflect on the strengths and weaknesses of our work and conclude
with suggestions for future research.
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Chapter 2

2

Literature review

2.1 Environmental heat
Rising ambient temperatures threaten to endanger human health. In conducting this
literature review we classified environmental heat as high ambient temperatures
originating from natural weather variation experienced at any time of day. This broad
definition of environmental heat may at times overlap and be compounded by aspects of
occupational heat, which can also originate from natural sources. However, occupational
heat is distinct in that it sometimes can stem exclusively from industrial sources and is
typically confined to the hours that workers are on the job (e.g. boiler room staff,
firefighters).26
Environment Canada once provided an official, country-wide definition of a heat wave as
three or more consecutive days when the maximum temperature was ≥32oC.27 However,
that definition is no longer in use and has been replaced by region-specific definitions of
heat events. Within the province of Ontario, Canada the maximum temperatures for
declaring heat alerts range between 29oC to 31oC depending on the location.28 In many
parts of Ontario, the number of days reaching above 30oC between 2021-2040 is
predicted to double compared to those observed between 1961-1990.29 With high heat
periods expected to become more frequent, detriments to public health are likely
imminent.30,31

2.2 Effect modifiers of heat-health relationships and risk
factors for heat-related illness
Vulnerability to environmental heat is not uniform. Age, biological sex, comorbidities,
medications, residential status, and socioeconomic status may modify heat-health
relationships (third level variable) and/or directly alter the risk of heat-related illness
(independent variable).
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2.2.1

Age

Age is a prominent modifier of the relationship between heat and mortality. In August
2003, a heat wave struck France resulting in roughly 15,000 excess deaths, the majority
of which were concentrated among the community-dwelling elderly. 32 Increased age also
appears to negatively modify the relationship between heat and morbidity.14,33 One study
out of New South Wales showed that for those aged 75 and older, the risk of all-cause
emergency department visits increased by 8% (relative risk [RR] 1.08, 95% confidence
interval [CI] 1.04 to 1.11) during heat waves, verses an increase of 1% (RR 1.01, 95% CI
1.00 to 1.02) in the under 75 age group.14 A formal statistical test for interaction by age
group was not performed.14
Several risk factors for heat-related mortality occur more frequently with older age as the
human body’s ability to withstand environmental heat declines.34 During periods of
dehydration, elderly individuals demonstrate impaired thirst recognition as well as
diminished conservation of sodium and water.19 On top of thermoregulatory deficiencies,
a lack of mobility may compound heat susceptibility.35 Being bed-bound (odds ratio [OR]
6.4, 95% CI 4.5 to 9.2), not leaving the home on a daily basis (OR 3.6, 95%CI 1.6 to 6.9)
and the inability to administer self care (OR 3.0, 95%CI 1.8 to 4.8) have all been
identified as prognostic factors associated with increased odds of death during heat
waves.36

2.2.2

Biological sex

Evidence for whether biological sex modifies heat-health relationships is conflicting and
may be outcome dependent. Some studies have identified increased heat-related
morbidity in males,37–39 explicitly for cardiovascular outcomes such as stroke,40 and acute
myocardial infarction.41,42 Yet, other studies have identified increased heat-related
mortality in females. 32,43–46 Whether biological mechanisms underscore these observed
sex differences in morbidity and mortality is poorly understood.40 It is also possible that
the observed sex differences are derived from behavioral discrepancies (e.g. likelihood to
engage in outdoor activities).38 Alternatively, the supposed sex differences may be a
statistical byproduct. For instance, the higher suggested heat-related mortality in females
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may result from residual confounding. Based on natural age structures and longer life
expectancies, older segments of the population are often comprised of greater proportions
of females.43 Moreover in studies that do not control for income, it is possible that age
and sex act as proxies for socioeconomic status. Therefore, effect estimates may differ in
relation to the specific control variables included within the statistical models of each
study.

2.2.3

Comorbidities

The impact of environmental heat on human health should be assessed in accordance
with comorbidity status, which can both modify heat-health relationships and serve as a
direct risk factor for heat-related illness.
Diabetes has been shown to act as an effect modifier intensifying susceptibility to heat
stress. Hallmark features of diabetes such as poor glucose control, changes in insulin
kinetics and diabetic neuropathy may adversely impact heat tolerance.47 In diabetics, the
ORs for mortality during episodes of extreme heat, compared to non-heat episodes, range
from 1.01 to 1.17.48,49
Deaths during heat waves have also been associated with the following risk factors: preexisting psychiatric illness (OR 3.6, 95% CI 1.3 to 9.8), cardiovascular illness (OR 2.5,
95% CI 1.3 to 4.8), and pulmonary illness (OR 1.6, 95% CI 1.2 to 2.1).36

2.2.4

Medications

Certain medications appear to be potent risk factors for morbidity and mortality during
heat spells. Medications have the potential to interfere with adaptive heat responses by
antagonizing water retention, reducing heart rate, blocking autonomic input, curtailing
sweat production, hampering visceral blood flow, and decreasing renal function.50
Despite the vast potential for harm, there is limited evidence linking medication use to
heat-related morbidity and mortality.
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Psychotropic drugs seem to be especially hazardous during times of high heat since their
actions on neuronal inputs can interfere with heat dissipation.50 During the Western
European August 2003 heat wave, the use of any psychotropic drug was associated with a
29% (95% CI 22% to 37%) increase in risk of death for elderly individuals aged 70 to
100 years.51 Moreover, there was a significant dose-response relationship between the
number of psychotropic drugs and risk of death (adjusted OR for linear trend 1.25, 95%
CI 1.21 to 1.29), with the highest effect estimates found for antidepressants (adjusted OR
1.71, 95% CI 1.57 to 1.86), and antipsychotics (adjusted OR 2.09, 95% CI 1.89 to
2.35).51 Another study that focused on hospital admissions during the same 2003 heat
wave yielded analogous main effect estimates.52 The meta-analysis by Bouchama et al.
reinforced the dangers, demonstrating that psychotropic drug use during heat waves
increased the pooled odds of death almost two-fold (OR 1.9, 95% CI 1.3 to 2.8).36

2.2.5

Residential status

The built environment and human activity alter surface temperature conditions. The
urban heat island is an example of this, whereby air temperatures in metropolitan regions
are elevated in comparison to surrounding non-metropolitan regions.53 Temperatures in
urban centers have been recorded to be between 2oC to 12oC higher than in nearby rural
areas.54 Urban heat islands are the culmination of many factors such as loss of vegetation
cover, sparse tree canopies, increased anthropogenic gases, and reduced ventilation.54,55
Pervasive dark sealed surfaces in urban areas also disrupt energy balances and interfere
with nocturnal cooling so that nighttime temperatures stay elevated. Under these
conditions, reprieve from the heat is limited. 56,57 Previous studies have found heat-health
effect estimates are modified by geographic region with more urban districts showing the
largest associations for mortality.56,58,59
In addition to having distinct physical landscapes, urban centers also exhibit high
settlement densities. Population density is a risk factor for heat stress with greater
densities achieved by residents dwelling in closer proximities.60 Living on the upper
floors of high rise apartment buildings has also been demonstrated to aggravate heatrelated morbidity.61,62
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Although not subject to urban heat islands or high settlement densities, rural settings are
still vulnerable to environmental heat stress for different reasons. Firstly, the catchment
areas for rural hospitals tend to be larger, meaning residents may have to travel further to
access care.63 Secondly, distinct lifestyle differences between urban and rural residents
persist. A Canadian study looking at daily time-activity patterns demonstrated that rural
seniors (aged 60 and over) spent on average 0.9 more hours outdoors per day compared
to urban seniors (p-value<0.001).64 Overall, rural residents were less likely to have an air
conditioner (43.0% vs. 57.2 %, p-value<0.001).64 Furthermore, 37.8% (95% CI 31.2% to
44.4%) of rural residents reported working in outdoor occupations verses only 23.1%
(95%CI 19.0% to 27.2%) of urban residents.64 Urbanites may be protected in this regard,
given that time spent indoors is significantly associated with lower personal heat
exposure.65
In the past, investigations specific to rural communities have been scarce because
meteorological monitors in these locations are usually spaced far apart. A contemporary
study used geostatistical kriging to interpolate heat stress and found the average rate of
emergency room visits in rural Southern, Ontario (defined as communities of <100,000
population) was 1.11 times higher (95% CI 1.07 to 1.15) during a heat wave than during
control periods.63 As temperature modeling systems continue to improve, it is critical to
consider the unique challenges faced by rural communities in juxtaposition to their urban
counterparts.

2.2.6

Socioeconomic status

Socioeconomic status has been shown to modify temperature-health relations.66,67 Lower
SES has also been implicated as a risk factor for heat-related illness.68,69 A study of the
1980 heat wave in St. Louis and Kansas City, United States found age-adjusted rates of
heatstroke were six-fold higher in the lowest SES quartile compared to the highest SES
quartile.68 Correspondingly, during the 2009 heat wave in Adelaide, Australia, hospital
admissions for heat-related illness more than doubled for individuals in the lowest SES
quartile compared to individuals in the other quartiles (OR 2.10, 95% CI 1.09 to 4.04).69
Poor quality housing and lack of access to air-conditioning are circumstances that are
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believed to contribute to the observed increases in heat-related morbidity and mortality in
individuals of low SES.70

2.3 Acute kidney injury
Acute kidney injury (AKI) was formerly referred to as acute renal failure. In conducting
this literature review, AKI was used exclusively and was considered to encompass the
more narrowly defined acute renal failure.
AKI is a serious clinical condition characterized by an abrupt decline in kidney
function.71 AKI is classified along a spectrum of pathology, ranging from mild to severe,
and occurs over a continuum of time, spanning from hours to days.72 A cornerstone of
AKI is the build-up of serum creatinine (SCr) and other nitrogenous waste products in
response to diminishing glomerular filtration rates (GFR).73 In the majority of patients,
the deterioration in kidney function is also followed by a decrease in urine output.74
Based on the most recent consensus guidelines, AKI can be diagnosed if one of the
following criteria is fulfilled: (I) SCr increase ≥ 0.3 mg/dl (≥ 26.5 µmol/l) within 48
hours; or (II) a ≥1.5-fold SCr increase within seven days (as compared to a known or
suspected baseline value); or (III) a reduction in urine output to < 0.5 ml/kg/day for at
least 6 hours.8
To date, epidemiological research has focused on well-defined cases of hospital-acquired
AKI. However, information on the frequency of community-acquired AKI is integral to
understanding external risk factors. One study that managed to quantify communitybased rates, observed that when comparing 1996-1997 to 2002-2003 the incidence of
non-dialysis requiring AKI in the general population rose from 323 (95% CI 317 to 329)
to 522 (95%CI 516 to 529) per 100,000 person years; while the incidence of more severe
dialysis-requiring AKI rose from 20 (95%CI 18 to 21) to 30 (95%CI 28 to 31) per
100,000 person years.75 Although AKI-associated mortality has decreased in the last few
decades in developed countries, the absolute number dying remains high because of
increasing incidence.76,77
AKI is estimated to afflict over 13 million people each year, placing a tremendous burden
on individual patients and international health-care systems at large.78 AKI is more
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common in the elderly79 and has been associated with significant mortality, development
of end-stage renal disease (ESRD), longer hospital stays, and inflated health care
costs.9,10 There are few proven therapies to reverse the damage of AKI. Acute dialysis is
the standard therapeutic option, but is not a direct treatment. Dialysis merely supplants
kidney function to allow time for healing. Even if the patient survives, full restitution of
kidney function is not guaranteed and depends in part on age, pre-existing disease, and
the extent of structural damage.80,81

2.4 Risk factors for acute kidney injury
Age, biological sex, chronic kidney disease, diabetes, cardiovascular disease, liver
disease, and certain medications have all been identified as risk factors for AKI.

2.4.1

Age

Increasing age is associated with increasing risk of AKI. Older adults are more
susceptible to AKI for several reasons; 1) increased prevalence of comorbidities, such as
diabetes and heart failure; 2) higher rates of diagnostic procedures and medical
interventions;82 and, 3) increased use of medications that either directly injure the kidneys
or indirectly interfere with the kidneys’ regulatory capacities.79
Further compounding the vulnerability of older adults are anatomical and physiological
problems with the kidneys themselves. Age-based structural impairments include
decreases in total renal mass, glomerulosclerosis, vessel wall thickening, and tubule
loss.12 Functionally, these impairments translate into natural declines in GFR, usually
beginning in the fourth decade of life (30 to 39 years of age).15,83
It is probable that the rising incidence rates of AKI are tied to aging population
structures.75,84,85 Community-based incidence rates of AKI have been observed to
increase from 815 per 100,000 person-years (95%CI 801 to 828) in those aged 60 to 69,
to 1809 per 100,000 person-years (95% CI 1784 to 1835) in those aged 70 to 79, all the
way up to 3545 per 100,000 person-years (95%CI 3481 to 3610) in those aged 80 and
over.75
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The high incidence of AKI in older adults is concerning given the poor prognoses for
members of this population. In a meta-analysis of 17 studies published between 2000 and
2007, it was shown that 31% of patients with AKI aged 65 and older were unable to
return to baseline kidney function or regain independence from renal replacement
therapy, compared to 26% of patients under age 65 (pooled RR 1.28, 95% CI 1.06 to
1.55).80

2.4.2

Biological sex

Males appear to be more susceptible to AKI than females.75,84,86 A study investigating
community-acquired AKI out of Canada, observed the annual incidence of severe AKI to
be 13 per 100,000 in males compared to 9 per 100,000 in females (RR 1.4, 95% CI 1.1 to
1.9).86 For those aged 65 and older, the sex difference was even greater with 70 per
100,000 males affected verses 32 per 100,000 females (RR 2.2, 95% CI 1.5 to 3.2).86
Additional work is needed to explain the underpinnings of these reported sex-differences
in AKI risk.

2.4.3

Chronic kidney disease

Chronic kidney disease (CKD) is defined by a baseline GFR of <60 ml/min/1.73m2
persisting for more than 3 months.87 It is distinguished from AKI by its longevity.
Despite having different timescales, the two conditions are closely interrelated.88
Research in this area has shown a graded relationship between progressive CKD stages
(lower estimated GFR categories) and escalating risk of AKI.89,90 A study from 1996 to
2003, found the adjusted ORs for dialysis-requiring AKI were 2.0 (95% CI 1.7 to 2.3),
6.5 (95% CI 5.6 to 7.7), 28.5 (95% CI 24.5 to 33.1), and 40.1 (95% CI 33.8 to 47.6)
comparing hospitalized adults with respective baseline estimated GFRs of 45-59, 30-44,
15-29, and <15 ml/min/1.73m2 to a non-CKD referent group with estimated GFRs ≥ 60
ml/min/1.73m2.89 An ensuing Canadian study from 2003 to 2006 found congruent results;
adjusted ORs for AKI were 2.9 (95% CI 2.7 to 3.1), 6.2 (95% CI 5.7 to 6.8), and 18.3
(95% CI 16.5 to 20.3) comparing hospitalized adults with baseline estimated GFRs of 4559, 30-44, and <30 ml/min/1.73m2 to a non-CKD referent group with estimated GFRs
≥60 ml/min/1.73m2. 90
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2.4.4

Diabetes

Diabetes is a potent risk factor for the development of AKI.91,92 In diabetes, the inability
to produce insulin leads to high blood glucose levels that progressively scar renal
vasculature and heighten susceptibility to acute insults. A population-based study of
adults in a Health Region of Alberta, Canada estimated the risk of severe communityacquired AKI to be 10.3 times higher in individuals with diabetes compared to those
without (RR 10.3, 95% CI 7.7 to 13.6).86 A case-control study comparing a sample of
hospitalized patients also demonstrated an association between hospital-acquired AKI
and diabetes, though the effect was dampened (adjusted OR 2.1, 95% CI 1.9 to 2.3).89

2.4.5

Cardiovascular disease

There is a reciprocal relationship between heart failure and worsening kidney function.
The two adverse outcomes often occur concomitantly with the failing heart accelerating
kidney under-perfusion, and vice-versa.93 A meta-analysis of 80,098 heart failure patients
classified 63% as having any renal impairment, with 29% having modest to severe
impairment.94 The adjusted all-cause mortality was significantly elevated in heart failure
patients with any renal impairment (hazard ratio [HR] 1.56, 95% CI 1.53 to 1.60) and
modest to severe renal impairment (HR 2.31, 95% CI 2.18 to 2.44) compared to heart
failure patients without renal impairment.94
Beyond heart failure, other cardiovascular conditions may also predispose to AKI. Severe
AKI has been found to develop more frequently among individuals with a history of heart
disease (RR 24.0, 95% CI 18.5 to 31.2) or stroke (RR 22.0, 95% CI 15.6 to 31.0).86 AKI
requiring dialysis has also been found to develop more frequently among hospitalized
adults with diagnosed hypertension.89

2.4.6

Liver disease

AKI is a potential sequela of liver disease, occurring in up to 20% of hospitalized patients
with cirrhosis.95 An analysis of intensive care-units in 16 countries found patients with a
history of cirrhosis were more than twice as likely to develop AKI than patients without a
history of cirrhosis (OR 2.18, 95% CI 1.16 to 4.10). 96 Development of AKI in patients
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with compromised liver function is an important prognostic factor, predicting increased
morbidity and mortality.97–100

2.4.7

Medications

Modulations in renal blood flow may trigger AKI. Three classes of drugs with the
capacity to induce AKI through hemodynamically mediated pathways are:
1) diuretics; 2) non-steroidal anti-inflammatory drugs (NSAIDs); and, 3) angiotensinconverting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs).101,102
Diuretics deplete fluid volumes and are known to increase AKI risk.103,104 A multi-center
prospective study identified diuretics as the second-leading cause of drug-induced AKI
accounting for 22% of cases.104
NSAIDs have also been associated with increased AKI risk.105 NSAIDs inhibit
prostaglandin production, which results in reduced dilation of the afferent arterioles in the
kidneys. When renal perfusion is inadequate, the NSAID-invoked limitations on intrarenal blood flow may lead to kidney damage.101 A meta-analysis of five observational
studies found that AKI risk was significantly elevated among traditional NSAID users in
comparison to non-users, with the pooled RRs for individual NSAIDs varying between
1.58 and 2.11.105 The association between NSAIDs and AKI is of concern due to the
widespread access and ubiquitous use of these drugs.106
Other frequently prescribed drugs that have been associated with increased AKI risk are
ACE inhibitors and ARBs. These drugs exert antihypertensive effects by interfering with
the production and binding of angiotensin-II. However, by disrupting the reninangiotensin system, ACE inhibitors and ARBs simultaneously limit the body’s ability to
compensate for volume losses.107 An ecological study in England approximated that up to
15% of the escalation in AKI admissions detected from 2007 to 2011 were attributable to
increases in ACE inhibitor and ARB prescribing rates.108
Diuretics, NSAIDs, and ACE inhibitors or ARBs may be even more dangerous when
taken in combination. A nested case-control study followed 487,372 antihypertensive
users for a mean of 5.9 years to show that triple therapy was associated with a 31%
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increase in AKI risk (RR 1.31, 95% CI 1.12 to 1.53) when compared to use of
antihypertensive drugs (diuretics and/or ACEis or ARBs) without NSAIDs.109 A
subsequent nested case control study of 78,379 antihypertensive users, also found that
triple therapy was associated with increased AKI risk (adjusted rate ratio 1.64, 95% CI
1.25 to 2.14) when compared to use of antihypertensive drugs without NSAIDs.110

2.5 Association between environmental heat and acute
kidney injury
We performed a detailed literature search of several bibliographic databases and
identified 10 studies that examined the association between environmental heat and AKI.
All of the studies (depicted in Table 2-1) found a significant association between various
heat indicators and increased risk of AKI.16–25 However, these studies were limited by
outcome measures with unknown or unmentioned validity,16–19,21–25 exclusive use of
coarse weather station data,16–20,22,24,25 and case-only designs that did not incorporate
external controls.16–25 In addition, the heat indicators were not chosen with the specific
etiology of AKI in mind because the majority of these studies set out to explore a
plethora of heat-related outcomes.16,18–21,23–25 Only two of these studies were focused on
renal disease.17,22 Moreover, the effect estimates were consistently small in magnitude.
Although small effect sizes are commonplace in environmental epidemiology,111 in light
of the limitations of these studies, it is difficult to discern whether the hypothesized heat
and AKI association is a true effect or merely an artifact of uncontrolled confounding.
Furthermore, over half of these studies were confined to California16,18,19,21,24 and
Australia.22 California is situated along the Pacific coast of the United States, and as a
result, has a Mediterranean-like climate with hot, dry summers and mild winters.112
While in Australia, the temperature threshold for defining heat events tends to be
considerably higher than in the northern hemisphere.113 The relationship between
environmental heat and the risk of AKI has not been adequately explored in regions with
more fluctuating temperature profiles. This is an important step because these regions
have a very different overall temperature experience due to tremendous variation between
long cold winters and short summers. For example in Ontario, Canada , winter
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temperatures can drop below -40oC; while summer temperatures can exceed 30oC.114
Although consistent hot temperatures are usually confined to June, July, and August, hot
episodes can also occur anomalously in the late spring and early fall months.115 Taken
together, the short summers and anomalous heat events may hinder adaptation thereby
altering the relationship between environmental heat and AKI in Ontario compared to
other settings.
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Table 2-1. Summary of key findings associating environmental heat with AKI
Population
(Outcome
Definition)
Time-Stratified Case-Crossover Studies
Author,
Year

Location,
Timeframe

Exposure

Basu et al.,
201216

California,
United States,
May-September,
2005-2008

21,650
Same day mean
emergency room apparent
visits with
temperature
principal
diagnosis of
AKI
(ICD-9: 584)

Fletcher et
al., 201217

New York State,
United States,
July-August,
1991-2004

12,370
hospitalizations
with a principal
discharge
diagnosis of
AKI
(ICD-9: 584)

Daily mean,
maximum, and
minimum values
of actual and
apparent
temperatures,
lagged by up to
5 days before
admission

Key Findings

- Odds of emergency
room visit with AKI
increased 15.9% per
5.6oC increase in same
day mean apparent
temperature (OR 1.159,
95% CI 1.127 to 1.193)

Limitations

- Ecologic-level
exposure data
(weather station data,
with 10 km radius)
- No information on
pre-existing illness
- Possible deviations
from linearity not
accounted for
- Odds of hospitalization - Ecologic-level
with AKI increased 9% exposure data
per 2.78oC in mean
(weather stations)
actual temperature at lag - No information on
1 (OR 1.09, 95% CI
mitigating resources
1.07 to 1.12)
- Failed to capture less
- Lags 0-2 showed
severe illness that did
significant increases in
not require inpatient
odds of hospitalization
admission
with AKI across all six
temperature indicators

Quality
Score
(0-281)
18

18

16

Green et al.,
201018

California,
United States,
May-September,
1999-2005

17,778 hospital
admissions with
a primary
diagnosis of
AKI
(ICD-9: 584)

Same day mean
apparent
temperature

- Odds of hospital
admission with AKI
increased 7.4% per 5oC
increase in same day
mean apparent
temperature (OR 1.074,
95% CI 1.040 to 1.109)

- Ecologic-level
exposure data
(weather stations with
10 km radius)
- No information on
mitigating resources
- Do not know validity
of coding practices
across hospitals and
diagnoses
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Ostro et al.,
201019

California,
United States,
May-September,
1999-2005

34,878 hospital
admissions with
a primary
diagnosis of
AKI
(ICD-9: 584)

Mean,
maximum, and
minimum daily
apparent
temperature

- Odds of hospital
admission with AKI
increased 10.2% per 5oC
increase in same day
mean apparent
temperature (OR 1.102,
95% CI 1.072 to 1.132)

- Ecologic-level
exposure data
(weather stations)
- Seasonal and longterm effects in
exposure series
minimized but not
eliminated
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12,676
hospitalizations
with AKI in
adults aged 65
years or older,
identified by

Heat wave
periods defined
as at least two
consecutive days
with average
daily

- RR of hospitalizations
with AKI increased to
1.14 (95% CI 1.06 to
1.23) on heat-wave days
compared to matched
non-heat wave days

- Ecologic-level
exposure data
(weather stations
within 35 km from
geometric center of
county)

20

Time-Series Analyses
Bobb et al.,
201420

United States,
1999 to 2010

17

clinical
classification
software
algorithm based
on ICD-9 codes

Guirguis et
al., 201421

California,
United States,
May-September,
1999-2009

An average of
57
hospitalizations
with diagnosis
of AKI
observed per
non-heat day
(ICD-9: 584)

Hansen et
al., 200822

Metropolitan
Area of
Adelaide,
Australia,
January 1,1995 December 31,
2006

3579 admissions
with discharge
diagnosis of
AKI
(ICD-10: N17)

temperatures
exceeding the
99th percentile of
the distribution
of daily
temperatures for
that county
Heat events
defined as
periods where
daily maximum
temperatures
and morbidity
were strongly
correlated and
both metrics
showed
anomalies

- Absolute risk
differences was 0.24
(95%CI 0.09 to 0.39)
excess daily hospital
admissions with AKI
per 100,000 individuals

- Average daily excess
hospitalizations with
AKI increased by a
count of 4.5 (95% CI
4.4 to 4.5) when
considering the entire
span of the heat health
event and by a count of
10.1 (95% CI 9.9 to
10.3) at heat wave peak
compared to non-heat
days
Heat waves
- IRR of hospital
defined as three admissions with AKI
or more
increased to 1.255 (95%
consecutive days CI 1.037 to 1.519)
with daily
during heat wave
maximum
periods compared to
temperatures
non-heat wave periods
th
≥95 percentile in the warm season

- Wide variety of
outcomes, multiple
testing

- Ecologic-level
exposure data
(weather station data
interpolated onto a 12
km x 12 km grid)
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- Ecologic-level
exposure data (single
weather station)
- No information on
mitigating resources
- Possibility of
miscoding
- Relatively small

17

18

Isaksen et
al., 201523

King County,
Washington,
United States,
May-September,
1999-2010

- 752,151
unplanned, nontraumatic total
hospital
admissions
- Number of
hospital
admissions with
the specific
diagnosis of
AKI not
specified
(ICD-9: 584)

(35oC) of
maximum
temperature
range for study
period
- RR analysis:
heat day defined
as day average
humidex
exceeded 99th
percentile of all
days, JanuaryDecember
(36.2 oC)
- Time-series:
cut-off defined
as 1.2oC above
99th percentile
(37.4 oC)

(November-March)

- RR of unplanned, nontraumatic
hospitalizations with
AKI increased to 1.68
(95% CI 1.41 to 2.01)
on a heat day compared
to a non-heat day
-Time-series: For every
1oC in daily maximum
humidex above 37.4oC,
hospitalizations with
AKI increased by 7.6%
(95%CI 3.2% to 12.2%)

number of admissions
- No medication
histories
- Insufficient control
of time trends
- Ecologic-level
exposure data
(gridded [1/16°]
resolution)
- No information on
mitigating resources
- Inappropriate
boundary selection
- No correction for
multiple comparisons
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Case-Only Analyses
Knowlton et
al., 200924

California,
United States,
July-August,
2006

- 13,829
hospitalizations
with a diagnosis
of AKI recorded
across any
diagnostic field

Heat wave
period defined
as July 15 to
August 1,
reference
periods defined

- RR of hospitalization
with AKI increased to
1.11 (95% CI 1.08 to
1.15) during heat wave
periods compared to
non-heat wave periods

- Limited to a single
heat wave

19

19

(ICD-9: 584)
Semenza et
al., 199925

Chicago,
United States,
July 1994,
July 1995

- 61 inpatient
admissions with
a primary
discharge
diagnosis of
AKI observed
during heat
wave
(ICD-9: 584),
only 13
admissions were
expected

as July 8-14 and
August 12-22
Heat wave
period defined
as July 13-19 of
1995, expected
counts averaged
across four
referent weeks
including July
6-12 of 1995
and July 6-12,
13-19, 20-26 of
1994

- 49 (95% CI: 31 to 66)
excess inpatient
admissions with a
primary discharge
diagnosis of AKI during
the heat wave compared
to reference periods

- Failed to capture less
severe illness that did
not require inpatient
admission
- Small sample size
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Abbreviations: AKI, acute kidney injury; CI, confidence interval; ICD-9 International Classification of Diseases, ninth revision; ICD-10, International
Classification of Diseases, tenth revision; IRR, incidence rate ratio; OR, odds ratio; RR, relative risk
1

We evaluated the quality of individual studies using the Black and Downs quality assessment checklist, which is a list of 27 criteria to evaluate both randomized

and non-randomized trials.116 This scale covers the completeness/clarity of study reporting, external validity, internal validity (e.g. bias and confounding) and
power. The tool was modified slightly for our use. Specifically, question 27 was simplified to a choice of awarding either 1 or 0 points depending on whether
there was sufficient statistical power to detect a clinically important effect. We gave all included studies a score from 0 to 28, according to the following four
quality categories: excellent (26 to 28), good (20 to 25), fair (15 to 19), and poor (less than or equal to 14).
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2.6 Conclusion
Environmental heat is recognized as the most common cause of weather-related fatalities
in high-income countries.117 However, the non-fatal effects of environmental heat are
underrepresented in the literature.118 One biologically plausible outcome that mandates
further attention is the development of AKI. Knowledge of the heat and AKI association
among older adults in Ontario,Canada is imperative because heat exposure is
avoidable.119 Public health action plans, that direct residents to cooling stations and issue
heat alerts, may be strengthened by a more thorough understanding of what types of
services are needed and for whom.
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Chapter 3

3

Objectives

The following objectives pertain to the population of older adults, 66 years and older,
residing in Ontario Canada.

3.1 Objective 1 - Costing
To describe the median 30-day government payer health care cost of a hospital encounter
with AKI.

3.2 Objective 2 – Impact of heat periods
To evaluate whether heat periods are associated with AKI.
We hypothesize that heat periods will be associated with a higher risk of AKI.

3.3 Objective 3 – Impact of high humidex periods
To evaluate whether high humidex periods are associated with AKI.
We hypothesize that high humidex periods will be associated with a higher risk of AKI.

3.4 Objective 4 – Effect modification by age
a) To evaluate whether the association between heat periods and AKI differs between
individuals aged 66 to 79 years versus those over 79 years.
We hypothesize that the association between heat periods and risk of AKI will be
elevated in individuals over 79 years compared to individuals aged 66 to 79 years.
b) To evaluate whether the association between high humidex periods and AKI differs
between individuals aged 66 to 79 years versus those over 79 years.
We hypothesize that the association between high humidex periods and risk of AKI will
be elevated in individuals over 79 years compared to individuals aged 66 to 79 years.
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3.5 Objective 5 – Evaluation of methodological approaches
a) To explore whether the association between heat periods and AKI is robust to different
methodological approaches.
We hypothesize that the association between heat periods and AKI will be consistent
across methodological approaches.
b) To explore whether the association between high humidex periods and AKI is robust
to different methodological approaches.
We hypothesize that the association between high humidex periods and AKI will be
consistent across methodological approaches.
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Chapter 4

4

Methods

4.1 Study design
We conducted a population-based, matched case-control study of older adults, aged 66
years and over, using Ontario’s linked health care administrative databases. These
datasets were linked using unique encoded identifiers and analyzed at the Institute for
Clinical Evaluative Sciences (ICES).
This study was approved by the institutional review board at Sunnybrook Health Sciences
Centre, Toronto, Canada. We followed a pre-specified analysis plan and adhered to the
REporting of studies Conducted using Observational Routinely-collected health Data
(RECORD) guidelines.120

4.2 Study population
Ontario is Canada’s most populous province. As of July 1, 2012, it was estimated that
approximately 2 million (15%) of Ontario’s roughly 13.5 million residents were aged 65
years and over, while more than 0.5 million (4%) of the total population were over 79
years of age.121 All Ontario residents’ receive universal access to hospital and physician
services under a single-payer health care system. However, individuals aged 65 years and
over also receive universal outpatient prescription drug coverage. Therefore, we restricted
our study to Ontario residents aged 66 years and over to ensure at least one year of
complete information on all dispensed drugs was available and could be included in our
analysis. Additionally, this age segment mandates specific attention because they are at
increased risk of heat illness34 and AKI.79

4.3 Timeframe and setting
The eight accrual periods of this study spanned from April 1st to September 30th of each
year from 2005 to 2012. We selected this timeframe because 2005 to 2012 were the only
years for which heat exposure data were available across the entire warm seasons. We
defined the warm seasons as April 1st to September 30th in order to capture the wide
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range of high temperatures experienced across Ontario in a given year. Ontario has a
humid continental climate typified by large seasonal variations; it is hallmarked by a
general temperature gradient that decreases moving from north to south and is tempered
by large bodies of water, especially the Great Lakes.122 Although June, July, and August
tend to be the hottest months with maximum temperatures exceeding 30oC, outlier heat
events can occur in the late spring and early fall. As of 2009, over 70% of Ontario
households had access to an air conditioning unit.123

4.4 Data sources
Administrative databases are compilations of digitized data generated whenever health
care is delivered.124 For instance, the date and time of patient appointments will often be
logged in a computerized system, as will any compensation claims made by physicians.
This creates digital footprints that can be linked to follow individual patients as they
navigate pathways of treatment. Although administrative data are not primarily collected
for research purposes, when used appropriately the data provide a fertile ground for
performing research.
Our study used a combination of administrative, clinical, survey, and weather data. In
total, we used seven databases to ascertain health outcomes, medication use, patient
characteristics, temperature exposures, and other covariate information.
1) Registered Persons Database (RPDB)
RPDB catalogues demographic information and vital statistics for any individual
who has been issued a health card number in Ontario. We used RPDB to identify
age, sex, and vital status information. RPDB also contains the best-known annual
postal code of residence for eligible persons as of July 1st each year. Postal codes
are six character strings defined for mailing purposes. At the time of this study,
there were over 280,000 postal codes in Ontario.125
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2) Census
The dissemination area (DA) is the smallest geographic region for which all
census data relevant to our study are released; approximately 400 to 700 persons
reside within each DA.126 We retrieved DA-level information on residential status
(rural vs. urban) and neighbourhood income quintile. We employed an ICES
definition to classify rural areas as those with a community size ≤10,000. Income
quintiles were categorized according to fifths of average neighborhood income.
These quintiles are constructed separately for each census metropolitan area,
census agglomeration, or residual area before being aggregated to the provincial
level.127 Consequently, the exact numerical values defining each quintile vary. We
instead used adjectival descriptors for the quintiles with 1 corresponding to the
lowest (poorest) quintile and 5 corresponding to the highest (richest) quintile.
3) Global Environmental Multiscale Surface (GEM-SURF) Database
GEM-SURF is an external forecasting system developed by Environment Canada.
The system accounts for land cover (e.g. built or natural) to accurately model
surface and near-surface meteorological variables with high resolution. In
previous studies, GEM-SURF weather predictions were shown to improve upon
existing methods.128–130
The 2006 census defined 19,177 DAs in Ontario. The GEM-SURF database at
ICES has daily weather summaries for 19,094 of these DAs. The missing DAs
were removed from GEM-SURF because they either had incomplete daily
weather summaries or their central grid points corresponded to bodies of water.
For the remaining DAs, we used daily weather summaries expressed as
percentiles of maximum temperature and maximum humidex. These percentiles
were specific to each DA and were created from the entire timespan of available
GEM-SURF data (June 1, 2004 to April 30, 2013).
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4) Canadian Institute for Health Information Discharge Abstract Database (CIHIDAD)
CIHI-DAD contains diagnostic and procedural information for all hospital
inpatient admissions in Ontario. Up to 25 diagnostic codes can be attributed by a
medical coder to a single hospitalization, while procedural codes are entered as
needed. One of the diagnostic codes must be labeled ‘M’ to indicate the condition
that was most responsible for the length of stay and resources used. Prior to 2002,
diagnostic codes followed the International Classification of Diseases, Ninth
Revision (ICD-9) and procedural codes followed the Canadian Classification of
Diagnostic, Therapeutics, and Surgical Procedures (CCP). From 2002 onward,
diagnostic codes followed the International Classification of Diseases, Tenth
Revision (ICD-10) and were accompanied by a new standard of procedural codes,
the Canadian Classification of Health Interventions (CCI). We used diagnostic
and procedural codes from these various classification systems to classify
comorbidity status using a five-year look back window. Since our accrual period
began in 2005, we used ICD-10 codes exclusively to identify cases with AKI.
Costing information was also obtained from CIHI-DAD.
5) Canadian Institute for Health Information National Ambulatory Care Reporting
System (CIHI-NACRS)
CIHI-NACRS contains diagnostic and procedural information for all emergency
department visits that have occurred in Ontario. Up to 10 diagnostic codes can be
attributed by a medical coder to a single emergency department visit. One of the
diagnostic codes is referred to as the main diagnosis to indicate the predominant
impetus driving the patient’s visit and need for treatment. We used CIHI-NACRS
to complement CIHI-DAD in identifying cases of AKI. We also obtained costing
information from the CIHI-NACRS database.
6) Ontario Drug Benefit (ODB) Database
All Ontario residents aged 65 and older qualify for coverage under the ODB
program. Written claims for outpatient prescription drugs dispensed under this

27

program are reliably transmitted to the ODB database. Each electronic claim in
the ODB database accurately identifies the unique drug dispensed, patient to
whom the drug was dispensed to, prescribing physician, date drug was dispensed,
number of days supplied, cost, and location of dispensing. The overall error rate
for electronic information in the ODB database compared to written prescription
information is 0.7% (95% CI 0.5% to 0.9%).131 We used the ODB database to
identify long-term care facility utilization and medication use.
7) Ontario Health Insurance Plan (OHIP) Database
This database houses information on all health care providers who submit claims
under OHIP, and includes data on inpatient and outpatient physician services. We
used the claims information captured in OHIP, in addition to diagnostic and
procedural information from CIHI-DAD, in identifying comorbidity status. We
also obtained costing information from the OHIP database.
These databases, with the exception of GEM-SURF, have been used repeatedly to study
the outcome of AKI.132–135

4.5 Data linkage and missingness
We linked individual records across datasets using unique, encoded personal identifiers
called ICES Key Numbers (IKNs). We then used the Postal Code Conversion File
provided by Statistics Canada to convert best annual postal codes of residence, available
for each individual record, to the corresponding DA.136 This allowed us to link
geographic attributes (from Census and GEM-SURF) to the IKNs using the assigned DAs
as the common element.
We were not able to convert the best annual postal code of residence to the corresponding
DA in <0.5% of individuals. Without an identifying DA, we could not link area-level
census attributes including residential status and neighbourhood-level income quintile.
Instead, we excluded cases and controls missing these attributes prior to matching.
Moreover, we were not able to link heat exposure information in <0.5% of individuals
because, as stated in Section 4.4, some DAs are missing form the GEM-SURF database.
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We excluded cases and controls with missing heat exposures after matching to allow for a
complete case analysis. Both of these exclusions are detailed in Figure 4-1 (cases) and
Figure 4-2 (controls). Information on all other variables was complete.

4.6 Identification of hospital encounters with acute kidney
injury
We defined hospital encounters with AKI by the presence of ICD-10 code N17, across
any diagnostic field in either the CIHI-DAD or CIHI-NACRS databases (see Appendix
B). In a former validation study, we tested the ‘all diagnoses’ N17 coding algorithm for
the ability to detect a ≥ 2-fold increase in serum creatinine (SCr) concentration from
baseline in Ontario’s 66 and over population.137 The sensitivity was found to be 61.6%
(95% CI 57.5% to 65.5%) for hospital admissions and 37.4% (95% CI 32.1% to 43.1%)
for emergency department visits; however in both of these settings, the specificity was
over 95%.137 For hospital admissions, the median absolute change in SCr was 98 µmol/l
(interquartile range [IQR] 43 to 200) in code positive patients and 6µmol/l (IQR -4 to 20)
in code negative patients.137 For emergency department visits, the median absolute
change in SCr was 133µmol/l (IQR 62 to 288) in code positive patients and 2 µmol/l
(IQR -8 to 14) in code negative patients.137 Although the incidence of AKI may be
underestimated by up to five-fold using the N17 code, the code does clearly distinguish
between groups of patients and is more likely to pick up the most severe cases of AKI, as
defined by greater elevations in SCr.

4.7 Selection of cases and controls
We selected all Ontario residents who had at least one hospital encounter (hospital
admission [CIHI-DAD] or emergency department visit [CIHI-NACRS]) with AKI during
the study period from April 1st, 2005 to September 30th, 2012 and who were at least 66
years of age at the time of the encounter. If persons had more than one hospital encounter
with AKI during the study period, we restricted our analysis to the first encounter. We
selected the first encounter during the study period in an attempt to identify incident AKI
cases because it is well established that the initial occurrence of AKI alters the risk of
recurrence.138,139 However, we were not able to rule out AKI encounters that occurred
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prior to April 2005. For inpatient admissions we considered the entire hospitalization as
one encounter, even if the patient was hospitalized at multiple facilities. We excluded
patients whose first encounter with AKI during the study period fell outside of the
relevant accrual windows (April 1st to September 30th of each year). For the remaining
cases, we designated the date of the hospital encounter as the index date.
We defined potential controls as all individuals who met the eligibility of cases, but did
not have a hospital encounter with AKI over the study period. We randomly selected
index dates for controls to match the distribution of index dates by cases, so that the
relative frequency of every day was equally represented across the two datasets. We
eliminated controls who did not meet the age restriction or had died prior to their selected
index dates.
The following exclusions applied to both cases and controls:
1) Receipt of dialysis in the year prior to index date, or, receipt of kidney transplant
in the five years prior to index date.
The development of AKI was not considered relevant in patients whose kidneys
were already failing.
2) Long-term care facility utilization prior to index date.
It was assumed residents’ exposures to ambient temperatures would be limited in
these climate-controlled facilities.
The coding definitions for these exclusions are listed in Appendix A.
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Figure 4-1. Selection of cases

Abbreviations: AKI, acute kidney injury; CIHI, Canadian Institute for Health Information; DAD, Discharge
Abstract Database; NACRS, National Ambulatory Care Reporting System; n, number; RPDB, Registered
Persons Database
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Figure 4-2. Selection of controls

Abbreviations: IKN, ICES Key Number; n, number; RPDB, Registered Persons Database
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4.8 Matching
There was an abundance of eligible controls in comparison to eligible cases. Hence, we
attempted to match up to four controls with each case. We selected four controls
wherever possible in an effort to increase statistical power.140 We chose to use a variable
ratio as opposed to a fixed ratio because we planned to match on several factors and we
did not want to discard valuable case information if a full set of four controls could not be
matched. We used a greedy method of matching without replacement. After a match was
made, it was never broken.
We matched on characteristics thought to be associated with heat exposure and/or AKI
risk. We matched controls to cases on exact index date, since heat exposure changes over
time; age (±2 years), since increased age amplifies AKI risk and may impact likelihood
of heat exposure;79 age group (66 to 79 years, over 79 years), to facilitate a preplanned
stratified analysis; sex, since males tend to exhibit greater risk of AKI;75,86 urban or rural
residential status (population, >10,000 or ≤10,000) since residential status may increase
risk of AKI and modify heat exposure,64,65 income (categorized into fifths of average
neighborhood income), since lower income may increase risk of heat exposure and
AKI,17,141,142 and history of CKD, since this condition increases risk of AKI.89,90 We used
the cohort of cases and controls produced from this initial methodological approach in
conducting all analyses unless explicitly stated otherwise.

4.9 Exposure
There is tremendous heterogeneity in the exposure measures used to examine heat-health
relationships. Many studies have used iterations of daily mean actual temperatures143–148
and maximum actual temperatures149,150 for their primary analyses. Whereas other studies
have used daily mean apparent temperatures16,18,46 or maximum apparent temperatures.151
Apparent temperature combines the effects of dry temperature and humidity to serve as
an index of human discomfort. 151,152 Overall, no single exposure measure stands out as
the best predictor of heat-related mortality across geographic regions and age groups.152
Rather, the chosen exposure measure tends to reflect practical challenges pertaining to
particular investigations.
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We chose to use daily maximum actual temperature to define our primary exposure and
daily maximum humidex to define our secondary exposure because these indices are easy
to interpret. They are also the same measures employed by public health authorities in
Ontario when issuing heat alerts. The daily maximum is the highest actual temperature
reached in a given DA over a 24-hour period, starting at 12:00 am midnight. Actual
temperature is measured independent of the moisture content in the air, and for this
reason we chose to explore humidex in a secondary analysis. Humidex was designed by
Canadian meteorologists to describe how hot weather feels.152 Akin to apparent
temperature, the humidex is unitless and integrates temperature and dew point to
characterize discomfort. A humidex of 30 to 39 is generally associated with some
discomfort; a humidex ≥40 is associated with great discomfort.153
We expressed daily maximum actual temperatures and daily maximum humidexes as
percentiles. We derived each set of percentiles based on the entire ranges of daily
temperatures and humidexes recorded in each DA from June 1st, 2004 to April 30th, 2013.
We created 19,094 sets of temperature percentiles and 19,094 sets of humidex percentiles
corresponding to the 19,094 DAs in the GEM-SURF database. We were driven to use
DA-specific percentiles based on the notion of acclimatization. By using percentiles we
were able to define environmental heat relative to what individuals were physically
accustomed to, a practice that has been substantiated elsewhere.143,145,154
Major findings suggest that the impacts of environmental heat on acute health outcomes
are quite immediate. In past studies, a consistent three-day lag structure (lag 02) has
emerged in the relationship between environmental heat and AKI.33,113,146,155 The short
delay between heat exposure and AKI is physiologically consistent with body water loss
over time and disrupted fluid balances from dehydration.7 Consequently, we chose to
implement a three-day lag structure in our study. Day 0 was defined as the index date,
day 1 was directly before the index date, and day 2 was two days before the index date.
The relationship between temperature and health outcomes tends to follow a “U”, “V”, or
“J”-shape with morbidity rapidly escalating beyond certain thresholds.46,145,147–150 We
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chose to dichotomize our exposures using the 95th percentile as our relative threshold.
Our decision to use the 95th percentile as the cut-point was motivated by existing
literature.40,113,156 We chose to dichotomize our exposures rather than model them as
continuous moving averages because we did not anticipate that the change in risk would
be the same for each stepwise increase in temperature. We also avoided continuous
moving averages because our intent was to study sustained high heat without allowing an
exceptionally hot day to skew the mean. Although ordinal exposures measures would
have allowed examination of non-linearity and possible dose-response relationships, we
decided against them because we expected heat effects to be confined to the extreme end
of the exposure scale157 and foresaw small cell sizes in upper percentile categories as a
limiting factor.158
We defined heat periods as three consecutive days (lag 0 [index], lag 1, and lag 2) where
the 95th percentile of daily maximum actual temperature was reached or exceeded. This
was our primary measure of environmental heat. We classified cases and controls that did
not meet the definition of a heat period as being unexposed.
We defined high humidex periods as three consecutive days (lag 0 [index], lag 1, and lag
2) where the 95th percentile of daily maximum humidex was reached or exceeded. This
was our secondary measure of environmental heat. We classified cases and controls that
did not meet the definition of high humidex periods as being unexposed.

4.10 Covariate adjustment
We consulted nephrologists and reviewed the literature in order to identify nonintermediary variables believed to be causally associated with AKI. We sought to adjust
for these variables in our analysis to correct for different predispositions to AKI among
cases and controls. In the five years prior to index date a history of diabetes, congestive
heart failure, coronary artery disease excluding angina, stroke, peripheral vascular
disease, chronic liver disease, and hypertension were identified for adjustment (Appendix
C); in the 120 days prior to index date evidence of prescriptions for angiotensinconverting enzyme (ACE) inhibitors alone, angiotensin II receptor blockers (ARB) alone,
ACE inhibitors and ARBs together, potassium-sparing diuretics, nonpotassium-sparing
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diuretics, non-steroidal anti-inflammatory drugs (NSAID) excluding aspirin, and
psychotropics were identified for adjustment.36,86,89,93,100,101,109,110,159

4.11 Costing
We attempted to provide perspective on the potential economic fallout of AKI by
determining the government payer health care costs on an individual basis. We tracked
government payer health care costs over a 30-day period starting on, and inclusive of, the
index date. We aggregated various costing data using only three sources: 1) inpatient
hospitalizations from CIHI-DAD, 2) emergency department and dialysis clinic visits
from CIHI-NACRS, and, 3) physician billings, non-physician billings and lab claims
from OHIP. This was a conservative approach and did not include several cost sources
such as same day surgery, medication, rehabilitation, and complex continuing care. CIHIDAD and CIHI-NACRS attribute resource intensity weights (RIW) to each individual to
describe the average amount of hospital resources (administration, staff, supplies,
technology, equipment, etc.) used by a patient with a particular condition relative to a
reference patient. RIWs are updated annually. To determine the base RIW, individuals
are first assigned to a case-mix group according to their most responsible/main diagnoses
and interventions received. The case-mix groups are further compartmentalized by age
category. After combining the case-mix group with the corresponding age category, each
individual’s base RIW is then adjusted to incorporate length of stay and comorbidity
status.160 The final RIW is multiplied by the hospital-specific cost-per weighted case to
estimate the individual hospitalization costs for that person. In OHIP, RIWs are not
applicable. Instead, the unit costs simply represent the fees paid for procedures or
consultations. All dollar values were harmonized to 2012.

4.12 Statistical analyses
We expressed continuous variables as medians (IQR) to account for possible skewed
distributions and categorical variables as proportions. We used standardized differences
to evaluate the distribution of covariates between cases and weighted controls after
matching. To calculate the standardized differences, we took the difference in the means
of each variable between cases and controls divided by the pooled standard deviation for
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that variable. In our study, a standardized difference >10% was considered to represent a
meaningful imbalance between cases and controls.161
We assigned a weight to controls by dividing the number of cases in a matched set
(always one) over the number of matched controls (one, two, three or four).162 Depending
on the number of controls in the matched set, possible weights included 1, 0.5, 0.33, or
0.25. The sum of control weights equaled the case sample size.
To better describe the scope and possible ramifications of AKI in our study, we
determined the number of unique hospitals that cases presented to along with the
proportion of cases who received acute dialysis during their hospital encounters. We
defined receipt of acute dialysis using OHIP feecodes (see Appendix B). We further
categorized cases by the top ten most responsible (CIHI-DAD) /main (CIHI-NACRS)
diagnoses.
We used several statistics to describe the underlying daily maximum temperatures and
daily maximum humidexes represented by the 95th percentiles in our sample of cases and
controls. We used ArcGIS software to map the daily maximum actual temperature
corresponding to the 95th percentile across all the 19,094 DAs for which GEM-SURF
data were available in Ontario.
We performed conditional logistic regression to estimate unadjusted and adjusted ORs
along with 95% CIs. We chose conditional logistic regression specifically to account for
correlation within matched sets. The adjusted analyses included all variables listed in
Section 4.9.
To quantify the effect of our primary analysis in absolute terms, we estimated the
population incidence rate of AKI in the absence of heat periods. We restricted our focus
to the warm season of 2012 and filtered through individuals DAs to exclude all dates
from April 1st, 2012 to September 30th, 2012 that met our definition of a heat period. In
other words, we combed through all 19,094 DAs to remove dates where on that day and
the two days prior (lag02) the 95th percentile of area-specific maximum temperature was
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reached or exceeded. We then linked the list of remaining non-heat dates for each DA to
RPDB and obtained the number of older adults, 66 years and over, in each dissemination
area on each non-heat date. We summed the number of persons at risk in each of the DAs
over all the non-heat period dates to obtain our person-time denominator. Next we
identified the number of hospital encounters with AKI that occurred over the same list of
non-heat period dates in the 66 and over population to obtain our numerator. We then
determined the absolute impact of heat periods on AKI by multiplying our adjusted OR
estimate (interpreted as RR) by the population incidence rate. We believe this
approximation was appropriate given the low incidence of AKI observed. Although we
only sampled controls who remained AKI free at the end of follow-up, rather than
sampling controls concurrently with cases, the number of older adults omitted from the
control series was relatively small.163 The rarity of AKI minimized the likelihood of an
overestimate.164

4.13 Additional analyses
To address our third objective, we conducted an analysis stratified by age groups:
1) those aged 66 to 79 years, and, 2) those over 79 years. We included an interaction term
in each model to assess whether the age group-specific odds ratios differed. We expected
to see higher OR estimates in the over 79 group because the elderly are known to be
vulnerable to environmental heat.34 We formatted the figure for this analysis using R
software.
To address our fourth objective, we examined the robustness of the estimates produced
using our initial matching approach by carrying out a subsequent round of matching. The
intent of this sensitivity analysis was to control for aspects of location by matching on
exact DA (inherently controls for residential status and income quintile), sex, age ± 2
years, age categories (66 to 79 years, over 79 years), and history of CKD. After matching,
we randomly reselected a new index date for controls to better account for seasonality,
long-term time trends and autocorrelation in the temperature exposure data. For each
control, the new index date was on a different date than the matched case, but on the
same day of week, within the same month, and year. This is a variant of the time-
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stratified method, which has been used extensively for referent selection in previous casecrossover studies.16–19,33,46,113,144,156,165 We performed exclusions in the control group with
respect to the new index dates. We did not need to factor the aforementioned time trends
into our primary analysis because cases and controls were compared on the same date.
However, we allowed the date to vary in the sensitivity analysis because, otherwise,
matching on exact DA and index date would result in cases and controls being assigned
identical exposure sequences.
We carried out another sensitivity analysis that was restricted to cases in our primary
cohort and looked at the time of presentation to the emergency department or admission
to the hospital at lag 0 (index date). The purpose of this analysis was to determine during
what time of day hospital encounters with AKI were most frequent and to investigate the
validity of temporality assumptions. Although we were able to definitively conclude that
daily maximum temperatures at lag 2 and lag 1 preceded the hospital encounters, we did
not know whether daily maximum temperatures at lag 0 tended to precede the hospital
encounters. We anticipated that daily maximum temperatures would peak, on average,
after 12:00 pm. If the majority of cases presented to the hospital after this time we would
suggest that, in most instances, heat exposure preceded the outcome.
Lastly, we explored the possibility of overmatching in our primary time-matched
analyses. To do so, we reduced matched sets by combining case and control groups with
exactly the same matching factors.166 We then reran the conditional logistic regression
analyses.
We conducted all statistical analyses in SAS software version 9.3 (SAS Institute). We
interpreted two-sided p-values less than 0.05 as statistically significant.
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Chapter 5

5

Results

5.1 Characteristics of cases and controls
Before matching, we isolated 66,732 cases of AKI and 1,710,783 eligible controls. From
this population, we matched 53,078 cases to 175,121 controls. After eliminating cases
and controls who were missing GEM-SURF temperature information, we ended up with
a total of 52,913 cases matched to 174,222 controls (Figure 4-1 and Figure 4-2). We
matched 36,424 (69%) cases to four controls, 3,680 (7%) cases to three controls, 4,677
(9%) cases to two controls and 8,132(15%) cases to one control. We created each
matched set without any prior knowledge of exposure status.
Characteristics of cases and weighted controls are presented in Table 5-1. Among both
cases and controls the median (IQR) age was 80 (74 to 85), 49% were female, 8% were
classified as having rural residential status, 24% lived in lowest income quintile
neighborhoods, and 16% had a history of CKD. Cases were more likely than matched
controls to be diagnosed with diabetes, congestive heart failure, coronary artery disease,
stroke, peripheral vascular disease, chronic liver disease, and hypertension. Cases were
also more likely than controls to have evidence of prescriptions for ACE inhibitors alone,
ARBs alone, both ACE and ARBs together, potassium sparing diuretics, non-potassium
sparing diuretics, NSAIDs, and psychotropics. Information for all of these variables was
complete.
Cases presented to 180 unique hospitals. In total, 2.7% (n=1440) of AKI cases received
acute dialysis during their hospital encounters. The top five most responsible/main
diagnoses recorded among cases were acute renal failure (18%), heart failure (6%), other
septicaemia (5%), other disorders of urinary system (4%), and acute myocardial
infarction (4%) (Appendix D). The median 30-day government payer health care cost
among AKI cases was $13,877 (IQR $8,399 to $24,449), compared to a $33 (IQR $0 to
$135) among controls.
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5.2 Descriptive characteristics of exposures
Summary statistics of the 95th percentile thresholds are presented in Table 5-2.
Aggregating the 227,135 case and control observations in our study, the 95th percentiles
corresponded to absolute daily maximum actual temperatures as low as 20.1oC and as
high as 32.5oC, and to absolute daily maximum humidexes as low as 20.1 and as high as
44.9. The 95th percentiles of daily maximum actual temperatures had an absolute median
of 30.2oC (standard deviation 1.3oC). The 95th percentiles of daily maximum humidexes
had an absolute median of 41.7 (standard deviation 2.4).
Heat periods did not always coincide with high humidex periods. Overall, heat periods
were moderately to strongly correlated with high humidex periods (Pearson correlation
coefficient=0.61, p-value<0.0001).
Figure 5-1 is a map of Ontario depicting the absolute daily maximum actual temperature
corresponding to the 95th percentile across all of the 19,094 DAs for which data were
available.

5.3 Association of acute kidney injury to heat periods and
high humidex periods
In our primary analysis, heat periods, compared to non-heat periods, were significantly
associated with risk of AKI (adjusted OR 1.11, 95% CI 1.00 to 1.23). In our secondary
analysis, high humidex periods were not significantly associated with risk of AKI
(adjusted OR 1.04, 95% CI 0.93 to 1.16). The full results from the time-matched cohort
are displayed in Table 5-3.
During the 2012 warm season and in the absence of heat periods, we identified 16,071
AKI events over 355,467,493 person-days at risk. This gives a baseline incidence rate of
roughly 1,650 cases of AKI per 100,000 person years in the absence of heat periods.
Therefore the 11% relative increase in risk of AKI associated with heat periods translates
to approximately 182 additional cases of AKI per 100,000 person-years, taking the warm
seasons as the time at-risk.
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5.4 Additional analyses
We conducted a subgroup analysis to determine whether there was effect modification by
age group. Contrary to our expectation, the association between heat periods and hospital
encounters with AKI did not differ across age groups (p-value 0.47). However there was
a significant difference in the association between high humidex periods and AKI across
age groups (p-value 0.01), with the association strengthened in those over 79 years.
Results of the age-stratified analysis are presented in Figure 5-2.
In our location-matched sensitivity analysis we ended up with 29,904 cases matched to
60,830 controls (Figure 4-1 and Figure 4-2). The distribution of characteristics for cases
and controls can be found in Appendix E. In this location-matched sensitivity analysis,
the adjusted OR for AKI was 1.11 (95% CI 1.00 to 1.23) during heat periods, compared
to non-heat periods. The adjusted OR for AKI was also elevated during high humidex
periods compared to non-high humidex periods (adjusted OR 1.20, 95% CI 1.09 to 1.33).
Results of the sensitivity analysis are displayed in Table 5-4.
We performed a subsequent sensitivity analysis to investigate what time of day cases
from our initial cohort were most likely to present to the emergency department or be
admitted to the hospital with a diagnosis of AKI. We found that on an hourly basis,
hospital encounters were most frequent between 4:00 pm and 5:00 pm, with the majority
of cases (n=36,515, 69%) presenting to the hospital after 12:00 pm noon. From these
results, we would suggest that temporality assumptions were met and that peak heat
exposure on the index date (lag 0) tended to precede the AKI events. We would further
stipulate that the remaining patients, who presented to the hospital with AKI before peak
heat hours (e.g. in the morning), would still have received substantial heat exposure from
the culmination of the previous two days (lag 1, lag 2) plus whatever time elapsed prior
to their hospital encounter on the index date (lag 0). We believe this is a reasonable
conclusion to draw given the high correlation between heat metrics from hour-to-hour. It
was necessary to carry out this analysis because temporality is a pre-requisite for
causation. Although we were not able to definitively attribute a causal influence of heat
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exposure to AKI, the results of this analysis support the possibility of a causal
connection.
Collapsing case and control groups to form strata with the same matching criteria did not
appreciably alter the OR estimates, indicating that the time-matched analyses were not
subject to overmatching.
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Table 5-1. Distribution of selected characteristics for AKI cases and controls in
time-matched analysis
AKI cases1

Weighted controls1

Standardized

(N=52,913)

(N=52,913)

differences2

Age (median, IQR)

80 (74-85)

80 (74-85)

0%

Over 79 years of age

27,149 (51.3%)

27,149 (51.3%)

0%

Women

25,688 (48.5%)

25,688 (48.5%)

0%

4,364 (8.2%)

4,364 (8.2%)

0%

1, low

12,502 (23.6%)

12,502 (23.6%)

0%

2

11,639 (22.0%)

11,639 (22.0%)

0%

3, middle

9,974 (18.8%)

9,974 (18.8%)

0%

4

9,726 (18.4%)

9,726 (18.4%)

0%

5, high

9,072 (17.1%)

9,072 (17.1%)

0%

Chronic kidney disease6

8,464 (16.0%)

8,464 (16.0%)

0%

Diabetes7

23,406 (44.2%)

14,260 (27.0%)

54%

Congestive heart failure

23,894 (45.2%)

6,302 (11.9%)

116%

disease8

25,557 (48.3%)

13,489 (25.5%)

71%

Stroke

4,998 (9.4%)

1,490 (2.8%)

41%

2,743 (5.2%)

714 (1.3%)

4,755 (9.0%)

1,340 (2.5%)

41%

44,808 (84.7%)

34,862 (65.9%)

65%

ACE inhibitors alone

21,772 (41.1%)

14,254 (26.9%)

44%

ARB alone

10,531 (19.9%)

7,943 (15.0%)

19%

1,907 (3.6%)

847 (1.6%)

18%

Variable
Demographics

Rural residential status3
Income quintile4

Comorbid conditions5

Coronary artery

Peripheral vascular
disease
Chronic liver disease
Hypertension

32%

Medications9

ACE inhibitors and
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ARB use
Potassium-sparing
diuretics

6,727 (12.7%)

2,189 (4.1%)

46%

31,584 (59.7%)

17,206 (32.5%)

83%

8,407 (15.9%)

5,880 (11.1%)

21%

11,258 (21.3%)

5,549 (10.5%)

44%

Nonpotassium-sparing
diuretics
NSAIDs, excluding
aspirin
Psychotropics

10

Abbreviations: ACE, angiotensin-converting enzyme; AKI, acute kidney injury; ARB, angiotensin II
receptor blocker; IQR, interquartile range; N, number; NSAID, non-steroidal anti-inflammatory drug
1

Data are presented as number (%) of individuals, unless otherwise stated

2

Standardized differences were derived by taking the difference in means between cases and weighted

controls over the pooled standard deviation. Standardized differences are less sensitive to sample size
compared to traditional hypothesis tests. Standardized differences > 10% were considered to represent
meaningful imbalances between cases and controls.
3

All residential areas where the community size was ≤10,000 individuals were classified as rural.

4

Income was categorized into fifths of average neighborhood income, with 1 indicating the lowest

(poorest) quintile and 5 the highest (richest) quintile on a relative scale.
5

With the exception of diabetes, all other comorbidities were assessed using diagnostic, procedural, and/or

fee codes logged in administrative databases in the five years prior to index date.
6

In Ontario, positive coding algorithm for detecting chronic kidney disease identifies older adults with

median (IQR) eGFR of 38 mL/min per 1.73 m2 (26 to 51); its absence identifies those with a median (IQR)
eGFR of 69 mL/min per 1.73 m2 (56 to 82). 167
7

Diabetes was defined using the Ontario Diabetes Database (ODD), which contains records on all Ontario

diabetic patients identified since 1991.
8

Coronary artery disease excluded diagnoses of angina.

9

Medication use was assessed in the 120 days prior to index date.

10

Psychotropics included antidepressants (selective-serotonin reuptake inhibitors, serotonin-norepinephrine

reuptake inhibitors) and antipsychotic medications.
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Table 5-2. Descriptive statistics of 95th percentile of daily maximum temperature and humidex among AKI cases and controls
Minimum

Median
(Percentiles 25th, 75th)

Maximum

Daily maximum temperature (oC)

20.1

30.2 (29.3, 30.7)

32.5

Daily maximum humidex1

20.1

41.7 (40.8, 42.3)

44.9

Abbreviations: oC, degrees Celsius
1

humidex = (air temperature in °C) + h. Where h = (0.5555)(E - 10); E= vapour pressure in hPa (mbar), given by: e = 6.11*exp[5417.753*((1/273.16)-(1/dewpoint))] with

exp = 2.71828. Dewpoint is expressed in kelvins (K) (temperature in K = temperature in °C + 273.16) and 5417.7530 is a rounded constant based on the
molecular weight of water, latent heat of evaporation, and the universal gas constant.168
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Figure 5-1. Map of 95th percentile of daily maximum temperature by dissemination area in Ontario, June 2004 to April 2013
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Table 5-3. Association of AKI with exposure to heat periods and high humidex periods in time-matched analysis
Unadjusted OR (95% CI)

Adjusted OR (95% CI)1

Heat periods2

1.07 (0.98, 1.16)

1.11 (1.00, 1.23)

High humidex periods3

1.02 (0.93, 1.12)

1.04 (0.93, 1.16)

Exposure

Abbreviations: AKI, acute kidney injury; CI, confidence interval; OR, odds ratio
1

Adjusted for diabetes, congestive heart failure, coronary artery disease excluding angina, stroke, peripheral vascular disease, chronic liver disease, hypertension,

angiotensin-converting enzyme (ACE) inhibitor use alone, angiotensin II receptor blocker (ARB) use alone, ACE inhibitors and ARBs use together, potassiumsparing diuretic use, nonpotassium-sparing diuretic use, non-steroidal anti-inflammatory drugs (NSAIDs) use, and psychotropic use.
2

Heat periods were defined as 3 consecutive days (lag 02) where area-specific daily maximum actual temperature was ≥ 95th percentile, and were compared to all

periods that did not meet this definition.
3

High humidex periods defined as 3 consecutive days (lag 02) where area-specific daily maximum humidex was ≥ 95th percentile, and were compared to all

periods that did not meet this definition.
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Figure 5-2. Age-based subgroup analyses of association between AKI and exposure to heat periods and high humidex periods

Abbreviations: AKI, acute kidney injury; CI, confidence interval
Notes: The vertical lines indicate 95% confidence limits. The squares indicate odds ratios. The size of the squares is proportional to the precision of the estimate
(the square is larger when the 95% CI is narrower).
1

Adjusted for diabetes, congestive heart failure, coronary artery disease excluding angina, stroke, peripheral vascular disease, chronic liver disease, hypertension,

angiotensin-converting enzyme (ACE) inhibitor use alone, angiotensin II receptor blocker (ARB) use alone, ACE inhibitors and ARBs use together, potassiumsparing diuretic use, nonpotassium-sparing diuretic use, non-steroidal anti-inflammatory drugs (NSAIDs) use excluding aspirin, and psychotropic use.
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Table 5-4. Association of AKI with exposure to heat periods and high humidex periods in location-matched sensitivity analysis
Unadjusted OR (95% CI)

Adjusted OR (95% CI)1

Heat periods2

1.08 (0.99, 1.17)

1.11 (1.00, 1.23)

High humidex periods3

1.14 (1.05, 1.24)

1.20 (1.09, 1.33)

Exposure

Abbreviations: AKI, acute kidney injury; CI, confidence interval; OR, odds ratio
1

Adjusted for diabetes, congestive heart failure, coronary artery disease excluding angina, stroke, peripheral vascular disease, chronic liver disease, hypertension,

angiotensin-converting enzyme (ACE) inhibitor use alone, angiotensin II receptor blocker (ARB) use alone, ACE inhibitors and ARBs use together, potassiumsparing diuretic use, nonpotassium-sparing diuretic use, non-steroidal anti-inflammatory drugs (NSAIDs) use, and psychotropic use.
2

Heat periods were defined as 3 consecutive days (lag 02) where daily maximum actual temperature was ≥ 95th percentile, and were compared to all periods that

did not meet this definition.
3

High humidex periods defined as 3 consecutive days (lag 02) where daily maximum humidex was ≥ 95th percentile, and were compared to all periods that did

not meet this definition.
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Chapter 6

6

Discussion

6.1 Overview of findings
This population-based, matched case-control study adds to the growing body of evidence
supporting a link between environmental heat and AKI risk in older adults. To our
knowledge, it is one of the first studies to find evidence of this association in Ontario,
Canada. Our primary results showed that AKI risk was positively associated with threeday relative heat periods (adjusted OR 1.11, 95% CI 1.00 to 1.23), compared with threeday non-heat periods. As hypothesized, our sensitivity analysis reinforced this estimate
(adjusted OR 1.11, 95% CI 1.00 to 1.23). The magnitude of our estimates for heat periods
broadly parallel previous findings.105, 109 Confirmation of this association strengthens our
hypothesis that this is a true effect.
The main effect of high humidex periods was more difficult to resolve. Only high
humidex periods, and not heat periods, showed a significant interaction effect by age
group. Compared to those aged 66 to 79 years, those over 79 years of age were at
increased risk of humidex-associated AKI. This is in line with past research documenting
impaired heat tolerance in the elderly.34
Our decision to define heat periods and high humidex periods by the 95th percentile
corresponds well with Environment Canada’s thresholds for issuing heat alerts. In
Southern Ontario a heat alert may be declared when over two consecutive days the daily
maximum temperature is expected to be ≥31oC and nighttime minimum temperature is
expected to be ≥20oC, or, when the daily maximum humidex is expected to be ≥40.28 In
Northern Ontario the thresholds are reduced to a daily maximum temperature of ≥29oC
and nighttime minimum temperature of ≥16oC, or, a daily maximum humidex ≥36.28
Extreme heat alerts use the same thresholds sustained over three or more days.28 In our
work, the overall median of the 95th percentile of maximum daily temperature was
30.2oC. The overall median of the 95th percentile of maximum daily humidex was 41.7.
This demonstrated that our exposure indicators actually represented high heat.
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By using percentiles in our work, we were able to apply a single definition of heat that
accounted for the relative experience of temperature across geographic locations in the
same way that Environment Canada uses multiple different thresholds for different parts
of Ontario. For example, the 95th percentile of daily maximum temperature in a remote
northern DA may have represented a raw reading of 28oC. Among individuals living in
this northern DA, 28oC would be a manifestation of heat compared to the temperatures
they typically experienced. In contrast, the 95th percentile of daily maximum temperature
in a more southern DA may have represented a raw reading of 31oC. Since this DA was
consistently hotter, it would follow that individuals living there would possess greater
adaptive mechanisms for dealing with heat and would be more likely to experience AKI
at 31oC than at 28oC. In summary, heat thresholds differed by region as a function of the
local climate along with the physiological and behavioral acclimation of residents.

6.2 Implications
The adjusted OR estimates in this study were quite small. However, our method of
detecting AKI lacked sensitivity and incidence may have been underestimated by up to
five-fold. In absolute terms, we approximated that heat periods associated with an
additional 182 cases of AKI per 100,000 person years during the warm seasons.
Considering the median 30-day government payer health care costs for a single AKI case
was $13,877, the costs of treating 182 cases of AKI may conceivably surpass $2.5
million CDN. With the average yearly temperature in Ontario projected to increase
another 2.3oC by the 2020s and as much as 4.1oC by the 2050s,169 it is probable that more
Ontario residents will soon be exposed to heat periods.
Heat-associated AKI can be averted, should the appropriate preventative measures be put
in place. To this end, air conditioning is one of the top protective interventions in
combatting the effects of environmental heat.66 During times of extreme heat the
provision of sufficient air-conditioned spaces, at community centers and other public
institutions, is pertinent.170 Increased transportation and extended operating hours to these
spaces is also recommended to facilitate accessibility. The city of Toronto, Ontario is a
good use case for why public cooling stations should be provided. In a survey that
included 184 residents, roughly half reported limiting their household use of air
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conditioners, citing costly energy bills as a limiting factor.171 Residents who choose not
to run their air conditioners, or who do not have access, may further exacerbate their risk
by improper usage of electric fans. Turning on a fan while the windows are closed, and
without intermittent air conditioning, simply recirculates hot air. This hinders radiative
and conductive heat loss and can hasten the process of dehydration.
Based on past research, the operational costs of running heat alert response programs are
minimal relative to the savings gained from effective prevention of heat-related morbidity
and mortality.172 A similar conclusion may be intuited from our results. The dollar values
we have reported do not encompass the social and emotional costs of having an AKI
event. Therefore coordinating announcements of heat warnings appears to be a promising
economic endeavor though more research is needed to confirm cost-effectiveness.
In order to maximize the effectiveness of heat warnings, outreach strategies and
messaging should be targeted to vulnerable groups.173 Taking our findings under
consideration, educational content on heat-related AKI may be particularly impactful
when framed for community-dwelling seniors. These individuals, who have retained their
independence, may be inclined to envisage themselves as resilient to heat despite
evidence to the contrary.174 An interview-based study of subjects aged 72 to 94 found
respondents generally recognized the elderly as vulnerable, though they did not perceive
themselves as elderly or vulnerable.175 Interestingly, the behavior of medical caregivers
may play into this misperception. An investigation of nursing home patients during the
2003 heat wave in France, demonstrated that the mortality rate in less dependent patients
was 8.3 times higher during the heat wave compared to before, but only 3.9 times higher
in the most dependent patients.176 The authors hypothesized that medical staff may have
been more prone to administer interventions to the highly dependent patients, thereby
preferentially preventing deaths in this group during the heat wave.176 The impartial focus
on the most dependent elderly patients may propagate erroneous beliefs that less
dependent elderly patients are immune to the negative impacts of heat. These narratives
of independence are persuasive and it is important that attitudes of autonomy and a lack
of knowledge regarding heat do not continue to amplify risk in the elderly population.
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Moving forward, educating the community-dwelling elderly on relevant heat-coping
strategies in a manner that does not undermine their independence should be a priority.
The educational content should stress the short-latency period of the proposed heat and
AKI association while emphasizing protective measures like air conditioning, increased
fluid intake, and avoidance of outdoor physical exertion. It is critical that this educational
content also be aimed at caregivers and physicians so that they too understand and can
discuss the AKI health risks with their patients.24,177

6.3 Implications of the selected study design
Considering our objectives and data constraints, we believe that the case-control design
was an efficient choice in comparison to a cohort-design.178 The case-control design is
tailored to explore individual associations between a single outcome and multiple
exposures using external controls. Furthermore, the large administrative databases at
ICES enabled us to identify a sufficient number of cases to examine associations with
precision. However, we do acknowledge that case-control studies are prone to selection
bias. We attempted to reduce this bias by selecting cases and controls independent of our
exposures of interest.
In the literature, time-series21,143,145–149,155,165,179 and case-crossover16–19,33,46,69,113,144,156,165
designs predominate. However, we did not feel that either approach was ideally suited to
our purposes.
Contemporary time-series analyses employ distributed lag non-linear models (DLNM).
When using the DLMN framework, outcome data are summed into daily-counts which
are treated as originating from an overdispersed Poisson distribution.180 Like the name
suggests, DLNMs are ideal for modeling the lagged structure of temperature-health
associations. In our study, the temporal delay was not a principal concern as we decided
to focus on a fixed three-day lag. The decision to stick with a single lag dimension was
guided by clinician expertise and findings from prior investigations.22,33,113,146 Another
reason we chose to forgo the use of DLNMs was because we foresaw numerous problems
with model convergence and wished to avoid performing case-only analyses. DLNMs
have been designed to be very flexible, with several mutable parameters. As a direct
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consequence, the inferences made from DLNMs may be conditional on post-hoc
selection of the best model fit. The standard practice has been to use DLNMs to obtain
area-specific risk estimates that can then be meta-analyzed to form an overall estimate.
Given the sheer number of possible DAs in the GEM-SURF database (19,094) and the
small number of cases within each, if applied to our work, this methodology would likely
have yielded issues with subjectivity, data suppression, and unreliable estimates.
In the case-crossover design each case serves as its own control. The design is
advantageous in that it accounts for all known and unknown confounding factors that do
not change with time.181 However, selecting referent days to compare exposures across
the same individual can be problematic. Sampling referents bidirectionally, both before
and after case events, achieves substantial reductions in bias from trends in the
exposure.182 Yet, the bidirectional sampling scheme is plagued by the assumption that
case events will not be repeated and that having an event will not influence subsequent
exposures.183 We were not prepared to make these assumptions as AKI is a repeatable
event and in many circumstances, the occurrence of AKI would likely have modified
subsequent behavior of the afflicted individuals. In our sensitivity analysis, we avoided
the need to make these assumptions by adapting the time-stratified referent selection
strategy of case-crossover studies to a set of external controls. We then used matching
techniques and multivariable adjustment to control for inter-individual variation.

6.4 Strengths
One strength of our study was focusing on the single outcome of AKI. We deliberately
prespecified our analyses to avoid an inflated type 1 error rate stemming from multiple
comparisons.
Another strength of our study was the use of microscale weather data. We capitalized on
the granularity of GEM-SURF temperature readings by matching cases and controls on
the exact same index date. By comparing matched cases and controls on the same date,
our primary analysis controlled for seasonality, long-term trends, and autocorrelation in
the exposure series. This circumvented the need for more complicated adjustment
approaches that may have introduced error.111 Matching on index date has not been
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possible in the past due to the reliance on weather station data that outputs uniform
temperature readings across expansive geographic regions. For example, in prior studies
data from the weather station at Pearson International Airport has been extrapolated to
cover all of Toronto.
By confining our analysis to the older adult population (66 years and over), we ensured
that personal medication histories could be included as control variables in our models.
Although this age restriction curtailed generalizability, it strengthened our study because
many drugs are known to increase heat-susceptibility and the risk of AKI through
alterations in fluid balance.34,36,184 Previous investigations that provided area-level
estimates were unable to incorporate information on personal medication histories.22,147
While other investigations that used case-crossover designs to provide individual-level
estimates also tended to omit information on personal medication histories, implicitly
assuming that there was no intra-individual variation. Seeing as medication use does vary
with time, this assumption may not have been entirely valid.

6.5 Limitations
The dependence on ecological exposure data is a shared limitation of ambient
temperature studies. Traditionally, ecological temperatures were designated to individuals
by mapping the individuals’ residential postal codes to the nearest weather
stations.16,18,19,113 In an effort to minimize misclassification bias, this process was often
extended to create circular buffers with pre-specified radial distances (e.g. 10 kilometers)
around each weather station. Only individuals for whom the geographic centroid of their
residential postal code fell within the buffers were included. Even with these safeguards
in place, it is probable that variable activity patterns introduced exposure error. The same
holds true in our study. Although we used GEM-SURF spatial models to provide more
targeted exposure data, temperature assignation was still done ecologically at the level of
the DA. We had no individual-level data on air conditioning use and work-leisure
schedules, both of which may have impacted heat exposure.19
To assign DAs, we used residential postal codes as opposed to hospital postal codes
because we wanted to apply a uniform technique of converting postal codes to
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geographic areas. Both cases and controls had residential postal codes listed in the RPDB
database, while only cases had applicable hospital postal codes. Inaccuracies may have
resulted from using the residential postal codes, as individuals do not always report
changes in addresses and do not always reside full-time at their primary addresses,
especially during the summer. The inaccuracies may have been most pronounced in the
controls. We would stipulate that controls were more likely than cases to leave their
primary dwellings as they were generally in better health. Future studies may benefit
from selecting controls with evidence of hospital encounters for conditions unrelated to
AKI. This would minimize exposure misclassification by enabling hospital postal codes
to be used uniformly for temperature assignation while simultaneously obviating the need
to randomly select index dates for the controls series.
Our study may also be limited by inappropriate geographic boundary selection 23 DAs are
defined for administrative uses and respect the boundaries of larger geographic units such
as census subdivisions and census tracts. They also vary considerably in physical size and
tend to be much larger in the north. Differences in temperature recorded between
neighboring grid points, or DAs, may be somewhat distorted particularly at the edges
where the DAs meet.185 We did not compensate for the possibility of edge effects.
Another limitation of our study is the heavy reliance on routinely collected administrative
data, which are not primarily intended for research purposes. When drawing together
information on covariates to adjust for, we were restricted to certain types of data, mainly
diagnostic codes, fee codes, and procedural codes. Our retrospective data sources did not
contain information on some proposed risk factors for heat-related AKI like exerciseexertion and water intake.
We lost a substantial number of cases during matching. It is possible that the distribution
of characteristics in these unmatched cases differs with respect to our matched cases.
Thus, the representativeness of our selected population remains in question.
Lastly, we failed to capture AKI events that did not result in a hospital encounter,
including out-of-hospital deaths. It is possible that our associations would have been
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strengthened had we had individual-level exposure information and more sensitive
outcomes measures.

6.6 Conclusion and future directions
AKI is a serious health complication. In accordance with previous work, the results of our
study suggest that AKI is positively associated with heat periods among older adults.
However, we cannot dismiss the possibility of residual confounding or the influence of
unmeasured confounders such as occupation26 and mental health.49,186 Up to this point,
inconsistent study designs and varied definitions of what comprises heat have inhibited
evidence synthesis. Rigorous methods, such as the implementation of percentiles to
quantify temperature on a transferable scale, are needed to support cross-investigation
comparisons. Whether to select geographic-varying exposures over time-varying
exposures as the optimal methodological approach also necessitates further research. The
generalizability of the heat and AKI relationship to broader age ranges warrants
investigation, as do the specific mechanisms underlying heat-related AKI. Incorporating
laboratory information (SCr) may aid in these endeavors by improving identification of
AKI events. Randomized controlled trials testing the efficacy of mitigation strategies
should also be considered. Knowledge of the types of interventions that are needed (e.g.
heat alerts, cooling stations), for whom, and at what regional level is required to inform
policy decisions and public health planning.
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Appendices
Appendix A: Definitions of preliminary exclusions
Variable

Database(s)

Code(s)

Dialysis in the year prior
to index date. This
includes any dialysis
modality (e.g. acute,
chronic, access creation).

CIHI-DAD

ICD-9: V451, V560, V568, 99673
ICD-10: T824, Y602, Y612, Y622,
Y841, Z49, Z992
CCP: 5127, 5142, 5143, 5195, 6698
CCI: 1PZ21, 1OT53DATS,
1OT53HATS, 1OT53LATS,
1SY55LAFT, 7SC59QD, 1KY76,
1KG76MZXXA, 1KG76MZXXN,
1JM76NC, 1JM76NCXXN

OHIP

OHIP feecodes: R850, G324, G336,
G327, G862, G865, G099, R825,
R826, R827, R833, R840, R841,
R843, R848, R851, R946, R943,
R944, R945, R941, R942, Z450,
Z451, Z452, G864, R852, R853,
R854, R885, G333, H540, H740,
R849, G323, G325, G326, G860,
G863, G866, G330, G331, G332,
G861, G082, G083, G085, G090,
G091, G092, G093, G094, G095,
G096, G294, G295
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Kidney transplant in the
five years prior to index
date.

CIHI-DAD

CCI: 1PC85

OHIP

OHIP feecodes: S435, S434

Long-term care facility
utilization

ODB

Looked at most recent ODB
prescription prior to index date for
long-term care flag.

Abbreviations: CCI, Canadian Classification of Health Interventions; CCP Canadian Classification of
Diagnostic, Therapeutics, and Surgical Procedures; CIHI-DAD, Canadian Institute for Health Information
Discharge Abstract Database; dx, diagnosis; ICD-9 International Classification of Diseases, ninth revision;
ICD-10, International Classification of Diseases, tenth revision; ODB, Ontario Drug Benefit database;
OHIP, Ontario Health Insurance Plan claims database.
Note: Prior to 2002, diagnostic codes followed ICD-9 and procedural codes followed CCP. From 2002
onward, diagnostic codes followed ICD-10 and procedural codes followed CCI. ICD-9 and ICD-10 were
developed by the World Health Organization. CCP and CCI were developed by CIHI.
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Appendix B: Definitions of outcomes
Variable

Database(s)

Code(s)

Acute kidney injury

CIHI-DAD,

ICD-10: N17

NACRS
Receipt of acute
dialysis

OHIP

OHIP feecodes: R849, G323, G866,
G330, G331, G093, G095, G294,
G295

Abbreviation: CIHI-DAD, Canadian Institute for Health Information Discharge Abstract Database; ICD10, International Classification of Diseases, tenth revision; Ontario Health Insurance Plan claims database;
NACRS, National Ambulatory Care Reporting System database
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Appendix C: Definitions of demographic variables and comorbid conditions
Variable

Database(s)

Age

RPDB

Sex

RPDB

Annual postal code of

RPDB

Code(s)

Best known postal code for eligible
RPDB person on July 1st each year.

residence

Drew from previous census data and
information collected each time a
person makes contact with a health
care institution.
Residential status

CENSUS

Neighbourhood income

CENSUS

quintile
Chronic kidney disease

CIHI-DAD

ICD-9: 4030, 4031, 4039, 4040, 4041,
4049, 585, 586, 5888, 5889, 2504
ICD-10: E102, E112, E132, E142, I12,
I13, N08, N18, N19

OHIP
Diabetes

ODD

OHIP dx: 403, 585
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Congestive heart failure

CIHI-DAD

ICD-9: 425, 5184, 514, 428
ICD-10: I500, I501, I509, I255, J81
CCP: 4961, 4962, 4963, 4964
CCI: 1HP53, 1HP55, 1HZ53GRFR,
1HZ53LAFR, 1HZ53SYFR

OHIP

OHIP feecodes: R701, R702, Z429
OHIP dx: 428

Coronary artery disease

CIHI-DAD

ICD-9: 412, 410, 411
ICD-10: I21, I22, Z955, T822
CCI: 1IJ50, 1IJ76
CCP: 4801, 4802, 4803, 4804, 4805,
481, 482, 483

OHIP

OHIP feecodes: R741, R742, R743,
G298, E646, E651, E652, E654, E655,
Z434, Z448
OHIP dx: 410, 412

All stroke

CIHI-DAD

ICD-9: 430, 431, 432, 434, 435, 436,
3623
ICD-10: I62, I630, I631, I632, I633,
I634, I635, I638, I639, I64, H341,
I600, I601, I602, I603, I604, I605,
I606, I607, I609, I61, G450, G451,
G452, G453, G458, G459, H340
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Peripheral vascular

CIHI-DAD

disease

ICD-9: 4402, 4408, 4409, 5571, 4439,
444
ICD-10: I700, I702, I708, I709, I731,
I738, I739, K551
CCP: 5125, 5129, 5014, 5016, 5018,
5028, 5038, 5126, 5159
CCI: 1KA76, 1KA50, 1KE76, 1KG50,
1KG57, 1KG76MI, 1KG87,
1IA87LA, 1IB87LA, 1IC87LA,
1ID87, 1KA87LA, 1KE57

OHIP

OHIP feecodes: R787, R780, R797,
R804, R809, R875, R815, R936,
R783, R784,R785, E626, R814, R786,
R937, R860, R861, R855, R856,
R933, R934, R791, E672, R794,
R813, R867, E649

Chronic liver disease

CIHI-DAD

ICD-9: 4561, 4562, 070, 5722, 5723,
5724, 5728, 573, 7824, V026, 2750,
2751, 7891, 7895, 571
ICD-10: B16, B17, B18, B19, I85,
R17, R18, R160, R162, B942, Z225,
E831, E830, K70, K713, K714, K715,
K717, K721, K729, K73, K74, K753,
K754, K758, K759, K76, K77

OHIP

OHIP dx: 571, 573, 070
OHIP feecodes: Z551, Z554
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Hypertension

CIHI-DAD

ICD-9: 401, 402, 403, 404, 405
ICD-10: I10, I11, I12, I13, I15

OHIP

OHIP dx: 401, 402, 403

Abbreviations: CCI, Canadian Classification of Health Interventions; CCP Canadian Classification of
Diagnostic, Therapeutics, and Surgical Procedures; CIHI-DAD, Canadian Institute for Health Information
Discharge Abstract Database; dx, diagnosis; ICD-9 International Classification of Diseases, ninth revision;
ICD-10, International Classification of Diseases, tenth revision; ODB, Ontario Drug Benefit database;
ODD, Ontario Diabetes Database; OHIP, Ontario Health Insurance Plan claims database; RPDB,
Registered Persons Database
Note: Prior to 2002, diagnostic codes followed ICD-9 and procedural codes followed CCP. From 2002
onward, diagnostic codes followed ICD-10 and procedural codes followed CCI. ICD-9 and ICD-10 were
developed by the World Health Organization. CCP and CCI were developed by CIHI.
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Appendix D: Top ten main/most responsible diagnoses among AKI cases
First three
characters of

Description

Number of cases (%)

ICD-10 code
N17

Acute renal failure

9437 (17.8%)

I50

Heart failure

3299 (6.2%)

A41

Other septicaemia

2664 (5.0%)

N39

Other disorders of urinary system

2093 (4.0%)

I21

Acute myocardial infarction

2083 (3.9%)

J18

Pneumonia, organism unspecified

1943 (3.7%)

J44

Other chronic obstructive pulmonary disease

1790 (3.4%)

Z51

Other medical care

1153 (2.2%)

E11

Type 2 Diabetes mellitus

1138 (2.2%)

E86

Volume depletion

681 (1.3%)

Abbreviations: ICD-10, International Classification of Diseases, tenth revision

85

Appendix E: Distribution of selected characteristics for AKI cases and controls in
location-matched sensitivity analysis
AKI cases1

Weighted controls1

Standardized

(N=29,904)

(N=29,904)

differences2

Age (median, IQR)

78 (73-84)

78 (73-84)

0%

Over 79 years of age

13,696 (45.8%)

13,682 (45.8%)

0%

Women

15,604 (52.2%)

15,604 (52.2%)

0%

Rural resdience3

2,984 (10.0%)

2,984 (10.0%)

0%

1, low

7,387 (24.7%)

7,387 (24.7%)

0%

2

6,436 (21.5%)

6,436 (21.5%)

0%

3, middle

5,628 (18.8%)

5,628 (18.8%)

0%

4

5,496 (18.4%)

5,496 (18.4%)

0%

5, high

4,957 (16.6%)

4,957 (16.6%)

0%

1,554 (5.2%)

1,549 (5.2%)

0%

12,937 (43.3%)

7,564 (25.3%)

47%

12,653 (42.3%)

3,013 (10.1%)

97%

13,902 (46.5%)

7,176 (24.0%)

60%

2,738 (9.2%)

847 (2.8%)

33%

1,465 (4.9%)

345 (1.2%)

27%

2,761 (9.2%)

728 (2.4%)

36%

25,072 (83.8%)

19,394 (64.9%)

55%

12,264 (41.0%)

7,843 (26.2%)

39%

Variable
Demographics

Income quintile4

Comorbid conditions5
Chronic kidney
disease6
Diabetes7
Congestive heart
failure
Coronary artery
disease8
Stroke
Peripheral vascular
disease
Chronic liver disease
Hypertension
Medications9
ACE inhibitors alone
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ARB alone
ACE inhibitors and
ARB use
Potassium-sparing
diuretics
Nonpotassiumsparing diuretics
NSAIDs, excluding
aspirin
Psychotropics10

5,915 (19.8%)

4,197 (14.0%)

19%

1,049 (3.5%)

398 (1.3%)

17%

3,739 (12.5%)

1,118 (3.7%)

40%

17,376 (58.1%)

9,257 (31.0%)

70%

5,022 (16.8%)

3,466 (11.6%)

18%

6,691 (22.4%)

3,581 (12.0%)

34%

Abbreviations: ACE, angiotensin-converting enzyme; AKI, acute kidney injury; ARB, angiotensin II
receptor blocker; IQR, interquartile range; N, number; NSAID, non-steroidal anti-inflammatory drug
1

Data are presented as number (%) of individuals, unless otherwise stated

2

Standardized differences were derived by taking the difference in means between cases and weighted

controls over the pooled standard deviation. Standardized differences are less sensitive to sample size
compared to traditional hypothesis tests. Standardized differences >10% were considered to represent
meaningful imbalances between cases and controls
3

All areas where the community size was ≤10,000 individuals were classified as rural.

4

Income was categorized into fifths of average neighborhood income, with 1 indicating the lowest

(poorest) quintile and 5 the highest (richest) quintile.
5

With the exception of diabetes, all other comorbidities were assessed using diagnostic, procedural, and/or

fee codes logged in administrative databases in the five years prior to index date.
6

In Ontario, positive coding algorithm for detecting chronic kidney disease identifies older adults with

median (IQR) eGFR of 38 mL/min per 1.73 m2 (26 to 51); its absence identifies those with a median (IQR)
eGFR of 69 mL/min per 1.73 m2 (56 to 82). 167
7

Diabetes was defined using the Ontario Diabetes Database, which contains records on all Ontario diabetic

patients identified since 1991.
8

Coronary artery disease excluded diagnoses of angina.

9

Medication use was assessed in the 120 days prior to index date.

10

Psychotropics included antidepressant (selective-serotonin reuptake inhibitors, serotonin-norepinephrine

reuptake inhibitors) and antipsychotic medication.
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